Literature DB >> 9192287

Axonal cytoskeletal changes after non-disruptive axonal injury.

S S Jafari1, W L Maxwell, M Neilson, D I Graham.   

Abstract

In animal models of human diffuse axonal injury, axonal swellings leading to secondary axotomy occur between 2 and 6 h after injury. But, analysis of cytoskeletal changes associated with secondary axotomy has not been undertaken. We have carried out a quantitative analysis of cytoskeletal changes in a model of diffuse axonal injury 4 h after stretch-injury to adult guinea-pig optic nerves. The major site of axonal damage was the middle portion of the nerve. There was a statistically significant increase in the proportion of small axons with a diameter of 0.5 micron and smaller in which there was compaction of neurofilaments. Axons with a diameter greater than 2.0 microns demonstrated an increased spacing between cytoskeletal elements throughout the length of the nerve. However, in the middle segment of the nerve these larger axons demonstrated two different types of response. Either, where periaxonal spaces occurred, there was a reduction in axonal calibre, compaction of neurofilaments but no change in their number, and a loss of microtubules. Or, where intramyelinic spaces occurred there was an increased spacing between neurofilaments and microtubules with a significant loss in the number of both. Longitudinal sections showed foci of compaction of neurofilaments interspersed between regions where axonal structure was apparently normal. Neurofilament compaction was correlated with disruption of the axolemma at these foci present some hours after injury. We suggest that the time course of these axonal cytoskeletal changes after stretch-injury to central axons is shorter than those changes documented to occur during Wallerian degeneration.

Entities:  

Mesh:

Year:  1997        PMID: 9192287     DOI: 10.1023/a:1018588114648

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  25 in total

1.  Short-duration treatment with the calpain inhibitor MDL-28170 does not protect axonal transport in an in vivo model of traumatic axonal injury.

Authors:  Marek Ma; Luchuan Li; Xinran Wang; Diana L Bull; Frances S Shofer; David F Meaney; Robert W Neumar
Journal:  J Neurotrauma       Date:  2012-01-06       Impact factor: 5.269

2.  Calpastatin overexpression protects axonal transport in an in vivo model of traumatic axonal injury.

Authors:  Marek Ma; Frances S Shofer; Robert W Neumar
Journal:  J Neurotrauma       Date:  2012-08-29       Impact factor: 5.269

Review 3.  Axonal pathology in traumatic brain injury.

Authors:  Victoria E Johnson; William Stewart; Douglas H Smith
Journal:  Exp Neurol       Date:  2012-01-20       Impact factor: 5.330

4.  Unmyelinated axons show selective rostrocaudal pathology in the corpus callosum after traumatic brain injury.

Authors:  Thomas M Reeves; Terry L Smith; Judy C Williamson; Linda L Phillips
Journal:  J Neuropathol Exp Neurol       Date:  2012-03       Impact factor: 3.685

5.  Tensile stretching of cervical facet joint capsule and related axonal changes.

Authors:  Srinivasu Kallakuri; Anita Singh; Ying Lu; Chaoyang Chen; Ajit Patwardhan; John M Cavanaugh
Journal:  Eur Spine J       Date:  2007-12-14       Impact factor: 3.134

6.  A finite element infant eye model to investigate retinal forces in shaken baby syndrome.

Authors:  Steven Alex Hans; Sebastian Y Bawab; Michael L Woodhouse
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-04       Impact factor: 3.117

7.  Differential effects of FK506 on structural and functional axonal deficits after diffuse brain injury in the immature rat.

Authors:  Ann Mae Dileonardi; Jimmy W Huh; Ramesh Raghupathi
Journal:  J Neuropathol Exp Neurol       Date:  2012-11       Impact factor: 3.685

8.  Therapy development for diffuse axonal injury.

Authors:  Douglas H Smith; Ramona Hicks; John T Povlishock
Journal:  J Neurotrauma       Date:  2013-02-14       Impact factor: 5.269

9.  Mechanical breaking of microtubules in axons during dynamic stretch injury underlies delayed elasticity, microtubule disassembly, and axon degeneration.

Authors:  Min D Tang-Schomer; Ankur R Patel; Peter W Baas; Douglas H Smith
Journal:  FASEB J       Date:  2009-12-17       Impact factor: 5.191

10.  Chronic upregulation of activated microglia immunoreactive for galectin-3/Mac-2 and nerve growth factor following diffuse axonal injury.

Authors:  Charu Venkatesan; MaryAnn Chrzaszcz; Nicole Choi; Mark S Wainwright
Journal:  J Neuroinflammation       Date:  2010-05-27       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.